Correlation Between Ikena Oncology and X4 Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and X4 Pharmaceuticals, you can compare the effects of market volatilities on Ikena Oncology and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and X4 Pharmaceuticals.

Diversification Opportunities for Ikena Oncology and X4 Pharmaceuticals

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Ikena and XFOR is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and X4 Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ikena Oncology and X4 Pharmaceuticals

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.09 times more return on investment than X4 Pharmaceuticals. However, Ikena Oncology is 10.53 times less risky than X4 Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  173.00  in Ikena Oncology on August 30, 2024 and sell it today you would lose (4.00) from holding Ikena Oncology or give up 2.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ikena Oncology  vs.  X4 Pharmaceuticals

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
X4 Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Ikena Oncology and X4 Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and X4 Pharmaceuticals

The main advantage of trading using opposite Ikena Oncology and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.
The idea behind Ikena Oncology and X4 Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like